secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001437749-26-011116
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.02, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma amends warrants to enable equity classification; expects liability reduction
--------------------------------------------------------------------------------

- Amended warrants from 2023 and 2025 offerings to clarify stockholder vote cannot change beneficial ownership blockers.
- Prior classification as liabilities required recording a liability of $18.1M (Sep 2025) and $25.2M (Dec 2025).
- Expects warrant liability reduction and equity increase by the same amount after amendment.
- Issued unregistered in reliance on Section 3(a)(9) exchange and Section 4(a)(2) private placement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/0001437749-26-011116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000143774926011116/aytu20260327_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-011116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer